A U.S.-based biotech company says it has started a phase one coronavirus vaccine trial with financial support from a group backed by Bill Gates. The trial, taking place in Australia, involves about 130 people aged between 18 and 59. If it’s successful, the Maryland-based company will follow up with trials in more countries. Meanwhile, Dow futures jumped more than 200 points on Monday, on hopes of a coronavirus vaccine.
Subscribe to us on YouTube: https://goo.gl/lP12gA
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
Follow us on: